How biotechnology changes pharma R&D: a managerial perspective

Author： Chiesa Vittorio   Toletti Giovanni  

Publisher： Inderscience Publishers

ISSN： 0963-6048

Source： International Journal of Biotechnology, Vol.5, Iss.2, 2003-09, pp. : 125-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The collaborative economy of biotechnology: alliances, outsourcing and R&D

By Suarez-Villa Luis   Walrod Wallace  

International Journal of Biotechnology, Vol. 5, Iss. 3-4, 2004-05 ,pp. : 402-438

Inderscience Publishers

Access to resources Recommend Favorite

A comparison of R&D indicators for the Vancouver biotechnology cluster

By Salazar Monica   Bliemel Martin J   Holbrook J Adam  

Journal of Commercial Biotechnology, Vol. 14, Iss. 3, 2008-07 ,pp. : 233-246

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Editorial: R&D in biotechnology – The management challenges

By Shohet Simon  

Journal of Commercial Biotechnology, Vol. 10, Iss. 4, 2004-06 ,pp. : 301-303

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Industrial platforms-a unique feature of the European Commission's biotechnology R&D programme

By Aguilar A.   Ingemansson T.   Hogan S.   Magnien E.  

Trends in Biotechnology, Vol. 16, Iss. 9, 1998-09 ,pp. : 365-368

Elsevier

Access to resources Recommend Favorite

Changes to the European Union pharmaceutical legislation: Implications of the ‘Pharma Review’ for biotechnology companies

By Liikanen Erkki  

Journal of Commercial Biotechnology, Vol. 11, Iss. 1, 2004-10 ,pp. : 38-43

Palgrave Macmillan Ltd

Access to resources Recommend Favorite